Annual Drug Patent Expirations for CINVANTI
Cinvanti is a drug marketed by Heron Theraps Inc and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug.
This drug has seven patent family members in five countries.
The generic ingredient in CINVANTI is aprepitant. One supplier is listed for this compound. Additional details are available on the aprepitant profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
